RVPH
Reviva Pharmaceuticals Holdings, Inc.NASDAQHealthcare$0.79+0.89%ClosedMarket Cap: $2.7M
As of 2026-04-09
Insider Statistics (Q1 2026)
Purchases
3
Sales
0
Buy/Sell Ratio
0.00
Total Bought
$0.00
Total Sold
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Fri Mar 20 | Prabhu Narayan | officer: Chief Financial Officer | Sell | 40,925 | $1.87 | 40,925 |
| Fri Mar 20 | Bhat Laxminarayan | director, officer: President and CEO | Sell | 109,150 | $1.87 | 109,150 |
| Fri Mar 20 | Bhat Laxminarayan | director, officer: President and CEO | Sell | 40,925 | $1.87 | 40,925 |
| Fri Dec 19 | Funtleyder Leslie D. | director | Sell | 8,200 | $0.58 | 8,200 |
| Fri Dec 19 | Margolin Richard A | director | Sell | 8,200 | $0.58 | 8,200 |
| Fri Dec 19 | Patel Purav | director | Sell | 8,200 | $0.58 | 8,200 |
| Fri Dec 19 | SAXENA PARAG | director | Sell | 8,200 | $0.58 | 8,200 |
| Tue Feb 18 | Narayan Prabhu | officer: Chief Financial Officer | Sell | 194,250 | $1.80 | 194,250 |
| Tue Feb 18 | Bhat Laxminarayan | director, 10 percent owner, officer: President and CEO | Sell | 519,000 | $1.80 | 519,000 |
| Tue Feb 18 | Bhat Laxminarayan | director, 10 percent owner, officer: President and CEO | Sell | 181,500 | $1.80 | 181,500 |